Literature DB >> 17562715

Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificity.

James G Beeson1, Katherine T Andrews, Michelle Boyle, Michael F Duffy, Ee Ken Choong, Tim J Byrne, Joanne M Chesson, Alexander M Lawson, Wengang Chai.   

Abstract

Chondroitin sulfate (CS) A is a key receptor for adhesion of Plasmodium falciparum-infected erythrocytes (IEs) in the placenta and can also mediate adhesion to microvascular endothelial cells. IEs that adhere to CSA express var2csa-type genes, which encode specific variants of the IE surface antigen P. falciparum erythrocyte membrane protein 1 (PfEMP1). We report direct binding of native PfEMP1, isolated from IEs and encoded by var2csa, to immobilized CSA. Binding of PfEMP1 was dependent on 4-O-sulfated disaccharides and glucuronic acid rather than iduronic acid, consistent with the specificity of intact IEs. Using immobilized CS oligosaccharides as neoglycolipid probes, the minimum chain length for direct binding of PfEMP1 was eight monosaccharide units. Similarly for IE adhesion to placental tissue there was a requirement for 4-O-sulfated GalNAc and glucuronic acid mixed with non-sulfated disaccharides; 6-O-sulfation interfered with the interaction between placental CSA and IEs. The minimum chain length for maximal inhibition of adhesion was 10 monosaccharide residues. Partially 4-O-sulfated CS oligosaccharides (45-55% sulfation) were highly effective inhibitors of placental adhesion (IC(50), 0.15 microg/ml) and may have potential for therapeutic development. We used defined P. falciparum isolates expressing different variants of var2csa in adhesion assays and found that there were isolate-specific differences in the preferred structural motifs for adhesion to CSA that correlated with polymorphisms in PfEMP1 encoded by var2csa-type genes. This may influence sites of IE sequestration or parasite virulence. These findings have significant implications for understanding the pathogenesis and biology of malaria, particularly during pregnancy, and the development of targeted interventions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562715     DOI: 10.1074/jbc.M700231200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Characteristics of Plasmodium falciparum-infected-erythrocyte adhesion to chondroitin sulfate.

Authors:  James G Beeson
Journal:  Infect Immun       Date:  2008-06       Impact factor: 3.441

Review 2.  Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies.

Authors:  Miloni Thakkar; Brijesh S
Journal:  Drug Deliv Transl Res       Date:  2016-08       Impact factor: 4.617

3.  Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein.

Authors:  Ali Salanti; Thomas M Clausen; Mette Ø Agerbæk; Nader Al Nakouzi; Madeleine Dahlbäck; Htoo Zarni Oo; Sherry Lee; Tobias Gustavsson; Jamie R Rich; Bradley J Hedberg; Yang Mao; Line Barington; Marina A Pereira; Janine LoBello; Makoto Endo; Ladan Fazli; Jo Soden; Chris K Wang; Adam F Sander; Robert Dagil; Susan Thrane; Peter J Holst; Le Meng; Francesco Favero; Glen J Weiss; Morten A Nielsen; Jim Freeth; Torsten O Nielsen; Joseph Zaia; Nhan L Tran; Jeff Trent; John S Babcook; Thor G Theander; Poul H Sorensen; Mads Daugaard
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

4.  Binding affinity of Plasmodium falciparum-infected erythrocytes from infected placentas and laboratory selected strains to chondroitin 4-sulfate.

Authors:  Rajeshwara N Achur; Arivalagan Muthusamy; SubbaRao V Madhunapantula; D Channe Gowda
Journal:  Mol Biochem Parasitol       Date:  2008-02-14       Impact factor: 1.759

5.  Structural interactions in chondroitin 4-sulfate mediated adherence of Plasmodium falciparum infected erythrocytes in human placenta during pregnancy-associated malaria.

Authors:  Rajeshwara N Achur; Ikuko Kakizaki; Suchi Goel; Kaoru Kojima; SubbaRao V Madhunapantula; Atul Goyal; Misato Ohta; Sanjeev Kumar; Keiichi Takagaki; D Channe Gowda
Journal:  Biochemistry       Date:  2008-11-25       Impact factor: 3.162

6.  Molecular dissection of placental malaria protein VAR2CSA interaction with a chemo-enzymatically synthesized chondroitin sulfate library.

Authors:  Nobuo Sugiura; Thomas Mandel Clausen; Tatsumasa Shioiri; Tobias Gustavsson; Hideto Watanabe; Ali Salanti
Journal:  Glycoconj J       Date:  2016-06-10       Impact factor: 2.916

7.  Structural and biochemical characterization of Plasmodium falciparum 12 (Pf12) reveals a unique interdomain organization and the potential for an antiparallel arrangement with Pf41.

Authors:  Michelle L Tonkin; Silvia A Arredondo; Bianca C Loveless; Jason J Serpa; Karl A T Makepeace; Natarajan Sundar; Evgeniy V Petrotchenko; Louis H Miller; Michael E Grigg; Martin J Boulanger
Journal:  J Biol Chem       Date:  2013-03-19       Impact factor: 5.157

8.  How specific is Plasmodium falciparum adherence to chondroitin 4-sulfate?

Authors:  Suchi Goel; D Channe Gowda
Journal:  Trends Parasitol       Date:  2011-04-18

9.  Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.

Authors:  Marion Avril; Marianne J Hathaway; Anand Srivastava; Sébastien Dechavanne; Mirja Hommel; James G Beeson; Joseph D Smith; Benoît Gamain
Journal:  PLoS One       Date:  2011-02-07       Impact factor: 3.240

10.  Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: implications for mechanisms of action and resistance.

Authors:  Sumit Bhattacharyya; Kemal Solakyildirim; Zhenqing Zhang; Robert J Linhardt; Joanne K Tobacman
Journal:  Malar J       Date:  2009-12-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.